Intertek introduces new pharmaceutical services at ICSE 2013
10 Sep 2013
Stands 42D45 and 42M40 Hall 4.2
Intertek, the leading quality solutions provider to industries worldwide, will illustrate how its unique blend of analysis and formulation development services, bioanalysis, auditing, supply chain management and regulatory support is deployed to help pharmaceutical clients save costs whilst increasing their agility and reducing time to market for innovation during the International Contract Services Exhibition (ICSE) 2013.
ICSE, Frankfurt, Germany (22-24 October 2013), connects the pharmaceutical and biopharmaceutical community with expert service providers of reliable outsourcing solutions to some of today’s toughest challenges. Intertek experts will be available throughout the event to discuss your specific needs and illustrate, from case studies, on how we can help.
We will also announce new investments service expansion to support your needs. One includes our recent extension into a full service offering of formulation, analytical method development/ validation, physical characterisation, stability studies, QC release testing, regulatory affairs consultancy, bioanalysis and extractables / leachables studies for orally inhaled and intra-nasal products (OINDP) products.
Another expansion comes from our investment into increased capability for the characterisation of complex biologics such as antibody drug conjugates.
Information sessions will be held at our booth to explain the expertise behind these expansions and opportunities they can provide for your business.
Ashleigh Wake, Biotechnology Programme Manager said “Our clients value Intertek’s characterization capabilities and experience with even the most complex of biologics such as antibody drug conjugates. Meeting at ICSE presents a good forum for preliminary discussions on these complex studies.”
“Our clients tell us that our innovative approach to partnering programmes really deliver in helping our clients maximise the value from their resources” said Dr. Andrew Swift, Senior Vice President of Intertek Pharmaceutical Services. “Addressing today’s industry challenges for development pipelines under a duly rigorous regulatory environment and across complex supply chains is no mean feat. The benefits of our technical expertise coupled with zero compromise on quality and safety can truly deliver competitive advantages. Our teams look forward to sharing our experience during discussions with you at ICSE.”
Contacts:
Dr Lorna Kettle, Marketing and Communications Manager,
IntertekChemicals and Pharmaceutical
E: lorna.kettle@intertek.com, T: +44 161 721 1476
Intertek Chemicals & Pharmaceuticals
Intertek’s regulatory facilities in Europe (UK, Switzerland)
and the USA are regularly inspected by the UK Medicines and Health Regulatory
Authority (MHRA), Swissmedic and the US FDA. Intertek Chemicals & Pharmaceuticals
helps organisations across a wide range of industries to sharpen their
competitive edge by providing advanced measurement, expert consulting related
technical support services, and sustainability solutions. Our experts and
laboratories provide critical support to our clients in their global trade, not
just with data, but with essential knowledge to accelerate development of their
next generation products, to improve their manufacturing, products or
production processes or to enhance their efficiencies.
About Intertek
Intertek (ITRK.L) is the leading provider of quality and
safety solutions serving a wide range of industries around the world. From
auditing and inspection, to testing, quality assurance and certification,
Intertek people are dedicated to adding value to customers' products and
processes, supporting their success in the global marketplace. Intertek has the
expertise, resources and global reach to support its customers through its
network of more than 1,000 laboratories and offices and over 35,000 people in
more than 100 countries around the world. Visit www.intertek.com
Further Information: